Greenstreet Yvonne
CIK 0001446125 Name as filed on the most recent filing
Filed as Greenstreet Yvonne (29)
163 transaction lines · from 29 filings · filed 2018-03-28 to 2026-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
163 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,420 disposed | 456.64 | 1,105,068.80 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,132 disposed | 449.15 | 957,587.80 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,960 disposed | 454.84 | 891,486.40 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,255 disposed | 451.16 | 566,205.80 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,210 disposed | 452.43 | 547,440.30 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,069 disposed | 453.52 | 484,812.88 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 711 disposed | 448.07 | 318,577.77 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 604 disposed | 457.71 | 276,456.84 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 453 disposed | 450.17 | 203,927.01 | Form 4, filing 0001735276-25-000120 | |
| 2025-11-12 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 430 disposed | 458.42 | 197,120.60 | Form 4, filing 0001735276-25-000120 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,029 disposed | 452.69 | 918,508.01 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,642 disposed | 450.81 | 740,230.02 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,010 disposed | 451.86 | 456,378.60 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 999 disposed | 453.77 | 453,316.23 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 758 disposed | 449.79 | 340,940.82 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 741 disposed | 454.84 | 337,036.44 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 548 disposed | 448.77 | 245,925.96 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 446 disposed | 457.43 | 204,013.78 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 350 disposed | 446.53 | 156,285.50 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 221 disposed | 455.82 | 100,736.22 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 171 disposed | 447.92 | 76,594.32 | Form 4, filing 0001735276-25-000116 | |
| 2025-10-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 9 disposed | 457.64 | 4,118.76 | Form 4, filing 0001735276-25-000116 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 2,716 disposed | 454.04 | 1,233,172.64 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,646 disposed | 452.96 | 745,572.16 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,204 disposed | 454.84 | 547,627.36 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 514 disposed | 451.99 | 232,322.86 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 450 disposed | 449.92 | 202,464.00 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 195 disposed | 450.92 | 87,929.40 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 194 disposed | 447.98 | 86,908.12 | Form 4, filing 0001735276-25-000089 | |
| 2025-08-18 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 60 disposed | 455.82 | 27,349.20 | Form 4, filing 0001735276-25-000089 | |
| 2025-06-02 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 19,297 disposed | 306.00 | 5,904,882.00 | Form 4, filing 0001735276-25-000075 | |
| 2025-05-30 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 25,469 disposed | 304.00 | 7,742,576.00 | Form 4, filing 0001735276-25-000075 | |
| 2025-05-30 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 6,171 disposed | 306.00 | 1,888,326.00 | Form 4, filing 0001735276-25-000075 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,173 disposed | 243.36 | 285,461.28 | Form 4, filing 0001735276-25-000030 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,068 disposed | 242.37 | 258,851.16 | Form 4, filing 0001735276-25-000030 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 791 disposed | 244.41 | 193,328.31 | Form 4, filing 0001735276-25-000030 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 580 disposed | 245.26 | 142,250.80 | Form 4, filing 0001735276-25-000030 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 238 disposed | 246.18 | 58,590.84 | Form 4, filing 0001735276-25-000030 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 23 disposed | 247.35 | 5,689.05 | Form 4, filing 0001735276-25-000030 | |
| 2025-03-03 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 4 disposed | 248.36 | 993.44 | Form 4, filing 0001735276-25-000030 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 1,093 disposed | 242.44 | 264,986.92 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 461 disposed | 241.51 | 111,336.11 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 440 disposed | 243.23 | 107,021.20 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 284 disposed | 240.32 | 68,250.88 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 214 disposed | 244.11 | 52,239.54 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 158 disposed | 236.51 | 37,368.58 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 127 disposed | 239.18 | 30,375.86 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-28 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 123 disposed | 238.33 | 29,314.59 | Form 4, filing 0001735276-25-000023 | |
| 2025-02-14 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 300 disposed | 253.37 | 76,011.00 | Form 4, filing 0001735276-25-000012 | |
| 2025-02-14 |
Alnylam Pharmaceuticals, Inc. ALNY |
S, Open-market sale | 271 disposed | 252.50 | 68,427.50 | Form 4, filing 0001735276-25-000012 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 163
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Greenstreet Yvonne, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001446125
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6